Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

NAUT stock hub

Nautilus Biotechnology, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NAUTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

340.6M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

NAUT

In the news

Latest news · NAUT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-33.7

P25 -105.6P50 -46.5P75 -3.1

ROIC-20.2

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NAUT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

174

Groups with data

Currency

USD

Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001808805
Company name	Nautilus Biotechnology, Inc.
Country	United States
Country code	US
Cusip	63909J108
Employees	130
Employees Change	-25%
Employees Change Percent	-16.13
Enterprise value	$273.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US63909J1088
Last refreshed	2026-05-10
Market cap	$340.6M
Market cap category	Small-Cap
Price	$2.68
Price currency	USD
Sector	Healthcare
Sic	3826
Symbol	NAUT
Website	https://www.nautilus.bio

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-16.76%
FCF yield	-15.1%
P/B ratio	2.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-57.1M
Net Income Growth Quarters	5%
Net Income Growth Years	1%
Profit Per Employee	$-439,115
ROA	-19.77
Roa5y	-15.21
ROCE	-37.84
ROE	-33.69
Roe5y	-24.78
ROIC	-20.18

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	283.26%
Cagr3y	4.33%
Cagr5y	-23.23%
EPS Growth Quarters	5
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$177.8M
Cash	$95.9M
Current Assets	$98.8M
Current Liabilities	$8.3M
Debt	$28.9M
Debt Equity	$0.2
Equity	$144.4M
Liabilities	$33.4M
Long Term Assets	$78.9M
Long Term Liabilities	$25M
Net Cash	$67M
Net Cash By Market Cap	$19.67
Net Cash Growth	-38.8%
Net Debt Equity	$-0.46
Tangible Book Value	$144.4M
Tangible Book Value Per Share	$1.14
WACC	7.72

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	11.85
Net Working Capital	$-1.5M
Quick ratio	11.49
Working Capital	$90.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.56%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	282.91%
200-day SMA	1.84
3Y total return	13.56%
50-day SMA	2.9
50-day SMA vs 200-day SMA	50over200
5Y total return	-73.33%
All Time High	25.89
All Time High Change	-89.65%
All Time High Date	2021-02-08
All Time Low	0.62
All Time Low Change	332.26%
All Time Low Date	2025-09-04
ATR	0.26
Beta	0.75
Beta1y	0.03
Beta2y	1.21
Ch YTD	37.44
High	2.9
High52	4.31
High52 Date	2026-03-25
High52ch	-37.82%
Low	2.67
Low52	0.62
Low52 Date	2025-09-04
Low52ch	332.26%
Ma50ch	-7.59%
Price vs 200-day SMA	45.49%
RSI	44.38
RSI Monthly	54.02
RSI Weekly	57.06
Sharpe ratio	1.73x
Sortino ratio	3.28
Total Return	-0.56%
Tr YTD	37.44
Tr1m	-14.1%
Tr1w	-0.74%
Tr3m	32.02%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.14
Operating Income	$-64.1M
Price target	$4
Price Target Change	$49.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	47,218,092%
Float Percent	37.16%
Shares Insiders	32.25%
Shares Institutions	17.21%
Shares Out	127,078,855
Shares Qo Q	0.21%
Shares Yo Y	0.56%
Short Float	1.35%
Short Ratio	1.51
Short Shares	0.5

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-57.5M
Average Volume	278,914.2x
Bv Per Share	1.14
CAPEX	$-1.6M
Ch1m	-14.1
Ch1w	-0.74
Ch1y	282.9
Ch3m	32.02
Ch3y	13.56
Ch5y	-73.33
Ch6m	77.48
Change	-6.94%
Change From Open	-7.59
Close	2.88
Days Gap	0.69
Depreciation Amortization	1,622,000
Dollar Volume	691,306
Earnings Date	2026-04-28
Earnings Time	bmo
EBIT	$-64.1M
EBITDA	$-62.5M
EPS	$-0.45
F Score	1
FCF	$-51.4M
FCF EV Yield	-18.8x
FCF Per Share	$-0.4
Financing CF	1,301,000
Fiscal Year End	December
Founded	2,016
Investing CF	29,946,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-26
Ma150	2.21
Ma150ch	21.16%
Ma20	2.82
Ma20ch	-5.1%
Net CF	-18,612,000
Next Earnings Date	2026-07-30
Open	2.9
Optionable	Yes
Position In Range	4.35
Post Close	2.68
Postmarket Change Percent	2.61
Postmarket Price	$2.75
Ppne	30,266,000
Price Date	2026-05-08
Ptbv Ratio	2.36
Relative Volume	0.92x
Share Based Comp	6,038,000
Tr6m	77.48%
Us State	Washington
Volume	257,950

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NAUT pay a dividend?

Capital-return profile for this ticker.

Performance

NAUT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NAUT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+17.2%

Float: +37.2% of shares outstanding

Insider ownership

+32.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

NAUT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.4

Neutral momentum band

Price vs 200-day MA

+45.5%

50/200-day relationship not available

Beta (5Y)

0.75

Less volatile than the market

Sharpe ratio

1.73

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NAUT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current NAUT stock rating?

Nautilus Biotechnology, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full NAUT analysis?

The full report lives at /stocks/NAUT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for NAUT?

The latest report frames NAUT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the NAUT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.